Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 55

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 55
---
ary Shares that
would be issuable upon a cash exercise of the Series L Warrant and (y) two (2). As a result of this feature, we do not expect to receive any cash proceeds from the exercise of the Series L Warrants because it is highly unlikely that a Series L Warrant holder will elect to pay an exercise price in cash to receive one Depositary Share when they could elect the zero cash exercise price option to receive additional Depositary Share without paying an exercise price.

Exercise Limitation.
A holder will not have the right to exercise any portion of the Pre-Funded Warrants or Series L Warrants if the holder (together with
its affiliates) would beneficially own in excess of 4.99% (or, upon election of the holder prior to the issuance of any warrants, up to
9.99%) of the number of shares of our Depositary Shares outstanding immediately after giving effect to the exercise, as such percentage
ownership is determined in accordance with the terms of the warrants. However, any holder may increase or decrease such percentage to
any other percentage not in excess of 9.99%, upon at least 61 days’ prior notice from the holder to us with respect to any increase
in such percentage.

Transferability.
Subject to applicable laws, the Series L Warrants and Pre-Funded Warrants may be offered for sale, sold, transferred or assigned without
our consent.

Exchange Listing.
We do not intend to list the Series L Warrants or the Pre-Funded Warrants offered in this offering on any securities exchange or other
trading market. Without an active trading market, the liquidity of these securities will be limited.

Rights as a Shareholder.
Except as otherwise provided in the Series L Warrants or the Pre-Funded Warrants or by virtue of such holder’s ownership of our
Depositary Shares, the holder of a Series L Warrant or Pre-Funded Warrant does not have the rights or privileges of a holder of our Depositary
Shares, including any voting rights, until the issuance of Depositary Shares upon exercise of the warrant. Holders of Pre-Funded Warrants
and Series L Warrants have the right to participate in dividends and certain distributions as specified in the warrant.

Fractional Shares.
No fractional Depository Shares will be issued upon the exercise of the Pre-Funded Warrants or the Series L Warrants. Rather, the number
of Depository Shares to be issued upon the exercise of the Pre-Funded Warrants will be